Biotech

All Articles

ArsenalBio elevates $325M, pivots out of former lead possession

.Collection Biosciences is actually going on up. The tissue therapy provider has actually added $325...

Lilly- supported effective weight loss biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' cannabis usage medicine fails period 2b, steering Indivior to re-think $100M choice

.Aelis Farma's chances of protecting an easy, positive choice on a $100 thousand alternative payment...

ProKidney stops period 3 trial not needed to have for tissue therapy confirmation

.ProKidney has actually stopped among a set of period 3 trials for its own cell treatment for kidney...

Vaxcyte surges on 'sensational' 31-valent PCV succeed versus Pfizer

.Vaxcyte unveiled what professionals named "remarkable" period 1/2 information for its own 31-valent...

Recursion's brain disease trial presents scant documentation of effectiveness

.Recursion has stumbled with a very early test of its tech-enabled technique to medicine discovery, ...

Acepodia, Pfizer click with each other for chemistry-based cell therapy

.Call it a scenario of really good chemical make up: Acepodia, a biotech based upon Nobel Champion s...

Praxis epilepsy medication reduces confiscations in phase 2 litigation

.Practice Preciseness Medicines has actually scored yet another midphase succeed in epilepsy this ye...

Three directors resign as Dyne blog posts mixed information for DMD prospect

.After escaping a clinical hold several years back, Dyne Therapy has shown new period 1/2 informatio...

Arrowhead fires off period 3 records in uncommon metabolic condition in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its hand ahead of a prospective showdown along with...